Molecular biomarkers in acute myeloid leukemia

J Prada-Arismendy, JC Arroyave, S Röthlisberger - Blood reviews, 2017 - Elsevier
Acute myeloid leukemia (AML) is the most common acute leukemia in adults. The
pathophysiology of this disease is just beginning to be understood at the cellular and …

[HTML][HTML] Polychemotherapy with curcumin and doxorubicin via biological nanoplatforms: enhancing antitumor activity

M Ashrafizadeh, A Zarrabi, F Hashemi, A Zabolian… - Pharmaceutics, 2020 - mdpi.com
Doxorubicin (DOX) is a well-known chemotherapeutic agent extensively applied in the field
of cancer therapy. However, similar to other chemotherapeutic agents such as cisplatin …

S100A9 induces differentiation of acute myeloid leukemia cells through TLR4

M Laouedj, MR Tardif, L Gil, MA Raquil… - Blood, The Journal …, 2017 - ashpublications.org
Abstract S100A8 and S100A9 are calcium-binding proteins predominantly expressed by
neutrophils and monocytes and play key roles in both normal and pathological inflammation …

Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts

J Mondet, S Chevalier, P Mossuz - Molecules, 2021 - mdpi.com
Deregulations of the expression of the S100A8 and S100A9 genes and/or proteins, as well
as changes in their plasma levels or their levels of secretion in the bone marrow …

Neutrophil exosomes enhance the skin autoinflammation in generalized pustular psoriasis via activating keratinocytes

S Shao, H Fang, J Zhang, M Jiang, K Xue… - The FASEB …, 2019 - Wiley Online Library
Generalized pustular psoriasis (GPP) is a rare and severe inflammatory skin disease that
can be life‐threatening. Gene mutations are found in some cases, but its immune …

Bone marrow inflammation in haematological malignancies

MME de Jong, L Chen, MHGP Raaijmakers… - Nature Reviews …, 2024 - nature.com
Tissue inflammation is a hallmark of tumour microenvironments. In the bone marrow, tumour-
associated inflammation impacts normal niches for haematopoietic progenitor cells and …

Integrated nuclear proteomics and transcriptomics identifies S100A4 as a therapeutic target in acute myeloid leukemia

B Alanazi, CR Munje, N Rastogi, AJK Williamson… - Leukemia, 2020 - nature.com
Inappropriate localization of proteins can interfere with normal cellular function and drive
tumor development. To understand how this contributes to the development of acute myeloid …

S100A8 contributes to drug resistance by promoting autophagy in leukemia cells

M Yang, P Zeng, R Kang, Y Yu, L Yang, D Tang, L Cao - PloS one, 2014 - journals.plos.org
Autophagy is a double-edged sword in tumorigenesis and plays an important role in the
resistance of cancer cells to chemotherapy. S100A8 is a member of the S100 calcium …

S100A8 and S100A9 in hematologic Malignancies: from development to therapy

F Razmkhah, S Kim, S Lim, AJ Dania… - International journal of …, 2023 - mdpi.com
S100A8 and S100A9 are multifunctional proteins that can initiate various signaling
pathways and modulate cell function both inside and outside immune cells, depending on …

Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML–BFM and DCOG study groups

F Damm, F Thol, I Hollink, M Zimmermann, K Reinhardt… - Leukemia, 2011 - nature.com
Mutations in the NADP+-dependent isocitrate dehydrogenase genes 1 and 2 (IDH1 and
IDH2) have recently been found in adult acute myeloid leukemia (AML) patients with a …